IMPACT BIOMEDICAL
Impact Biomedical, Inc. (IMPACT), a company engaged in the development and marketing of biohealth security technologies.
IMPACT BIOMEDICAL
Industry:
Medical Medical Device
Address:
Spring, Texas, United States
Country:
United States
Website Url:
http://www.impactbiomedical.com
Total Employee:
1+
Status:
Active
Similar Organizations
Brazos Biomedical
Brazos Biomedical is a biomedical device development company.
Emanate Biomedical
Emanate Biomedical is a medical device company.
TriOs Medical
TriOs Medical is a medical device company.
Official Site Inspections
http://www.impactbiomedical.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 76.223.54.146
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Impact Biomedical"
About Us - Impact Biomedical
Impact Biomedical drives mission-oriented discovery and development to pursue new products and treatment options in specialty biopharmaceuticals and consumer healthcare. Our โฆSee details»
Impact Bio at a Glance:
Track Record in Organizational Leadership. Todd Macko. Todd Macko, CFO of Impact Biomedical, brings over 25 years of expertise in financial management. He joined DSS Inc., โฆSee details»
Impact BioMedical Inc. (NYSE American: IBO) - LinkedIn
Impact Biomedical, Inc. is at the forefront of developing breakthrough technologies that address some of the worldโs most pressing health challenges.See details»
Impact Biomedical - Crunchbase Company Profile & Funding
Impact Biomedical is a biopharmaceutical company that specialises in the research and development of new products in biopharmaceuticals and consumer healthcare.See details»
Investors - Impact Biomedical
Impact Biomedical Inc. is a unique provider of natural and plant-based technology and business partner in addressing unmet needs in human healthcare and wellness.See details»
Impact BioMedical Inc. (IBO) Company Profile & Overview - Stock โฆ
Nov 29, 2024 Impact BioMedical Inc. focused on discovery, development, and commercialization of products and technologies to address unmet needs in human healthcare and wellness for โฆSee details»
Impact Biomedical - Crunchbase Company Profile & Funding
Impact Biomedical, Inc. (IMPACT), a company engaged in the development and marketing of biohealth security technologies. Lists Featuring This Company. Edit Lists Featuring This โฆSee details»
Impact BioMedical Inc. - VentureRadar
Impact Biomedical drives mission-oriented research and development that advances drug discovery and development for the prevention, inhibition, and treatment of neurological, โฆSee details»
Impact BioMedical Inc. Introduces Leadership Team to Drive โฆ
NEW YORK, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and โฆSee details»
Impact Biomedical Company Profile - Office Locations ... - Craft
Oct 29, 2024 Impact Biomedical is a holding company funding research and developing intellectual property portfolio of products and treatment options in specialty biopharmaceuticals โฆSee details»
Impact BioMedical Inc. Introduces Leadership Team to
Sep 23, 2024 Suseck has been with Impact BioMedical since August 2023 and previously served as the chief operating officer of DSS BioHealth Holdings Inc., where he led company โฆSee details»
Impact BioMedical Inc. (NYSE American: IBO) Announces IPO โฆ
HOUSTON, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and โฆSee details»
Impact BioMedical Inc. Announces the Closing of its Initial Public ...
Sep 17, 2024 All of the shares of common stock are being offered by Impact BioMedical. Revere Securities, LLC is the sole book-running manager for the offering. We have issued to Revere โฆSee details»
Impact BioMedical - Products, Competitors, Financials, Employees ...
Impact BioMedical Inc. (NYSEAmerican: IBO): Targeting Chronic Diseases with Patented Breakthrough. Nov 18, 2024. Impact BioMedical Inc. (NYSEAmerican: IBO): Targeting Chronic โฆSee details»
Impact BioMedical Inc. (IBO) - Stock Analysis
5 days ago Impact BioMedical Inc. focused on discovery, development, and commercialization of products and technologies to address unmet needs in human healthcare and wellness for โฆSee details»
Impact BioMedical Inc. (NYSE: IBO) Announces 3Fโข US Patent Issue
HOUSTON, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (โIBOโ) is pleased to announce that the US Patent and Trademark Office has issued U.S. Patent No. 11,985,973 โฆSee details»
Impact BioMedical Inc. (NYSEAmerican: IBO): Targeting Chronic
Nov 18, 2024 Chronic inflammatory diseases, identified by the World Health Organization as the leading global health threat, are a key focus area. In this rapidly evolving landscape, Impact โฆSee details»
Impact BioMedicalโs Proprietary Equivir Compound to Treat Viral ...
Mar 3, 2022 The first step occurred when Impact BioMedical received its first Equivir patent (US 10,383,842), which focused on influenza, from the U.S. Patent and Trademark Office on โฆSee details»